Expression of c-Met Proto-oncogene in Metastatic Macrophage x Melanoma Fusion Hybrids: Implication of Its Possible Role in MSH-Induced Motility

Oncology Research

Volumn 14, Issue 3, 2003, Pages 163-174

  Chakraborty, Ashok K ^a   Kolesnikova, Natalia ^a   De Freitas Sousa, Josane ^b   Espreafico, Enilza Maria ^b   Peronni, Kamila Chagas ^b   Pawelek, John ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

c Met proto oncogene; Hybrid; Melanocyte stimulating hormone (MSH); Metastasis; Motility

Indexed keywords

ANTIBODY; CHEMOATTRACTANT; FIBRONECTIN; GLYCOPROTEIN; HEPATOCYTE GROWTH FACTOR ANTIBODY; INTEGRIN; INTERMEDIN; ISOBUTYLMETHYLXANTHINE; NEUTRALIZING ANTIBODY; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUSION; CELL MOTILITY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE FUNCTION; GLYCOSYLATION; HYBRID CELL; MACROPHAGE; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTO ONCOGENE;

EID: 0842284112     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003771013062     Document Type: Article

References (72)

1. Pawelek, J. M.. Melanoma as a macrophage/melanocyte hybrid and the symbiotic nature of eukaryotic cells. Melanoma Res. 3:75-76; 1993.
2. Rachkovsky, M.; Sodi, S.; Chakraborty, A. K.; Avissar, Y.; Bolognia, J.; Madison-McNiff, J.; Platt. J.; Bermudes, D.; Pawelek, J. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis 16:299-312; 1998.
3. Halaban, R.; Nordlund, J.; Francke, U.; Moellmann, G.; Eisenstadt, J. M. Supermelanotic hybrids derived from mouse melanomas and normal mouse cells. Somat. Cell Genet. 6:29-44; 1980.
4. Sodi, S. A.; Chakraborty A. K.; Platt, J. T.; Rosemblat, S.; Keh-Yen, A. ; Bolognia, J. L.; Rachkovsky, M. L.; Orlow, S. J.; Pawelek J. M. Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: Altered N-glycosylation as an underlying mechanism. Pigment Cell Res. 11:299-309; 1998.
5. Chakraborty, A. K.; Sodi, S.; Rachkovsky, M.; Kolesnikova, N.; Platt, J. T.; Bolognia, J. L.; Pawelek, J. M. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res. 60:2512-2519; 2000.
6. Rachkovsky, M., Pawelek, J. Acquired melanocyte stimulating hormone-inducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells. Cell Growth Differ. 10:515-524; 1999.
7. Chakraborty, A. K.; Funasaka, Y.; Ichihashi, M.; Sodi, S.; Bhattacharya, M.; Pawelek, J. Up-regulation of mRNA for the melanocortin-1 receptor but not for melanogenic proteins in macrophage x melanoma fusion hybrids exhibiting increased melanogenic and metastatic potential. Pigment Cell Res. 12:355-366; 1999.
8. Chakraborty, A. K.; Pawelek, J.; Ikeda, Y.; Miyoshi, E.; Kolesnikova, N. ; Funasaka, Y.; Ichihashi, M.; Taniguchi, N. Fus ion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminlytransferase V, β1-6 branching, and metastasis. Cell Growth Differ. 12:623-630; 2001.
9. Stossel, T. P. How cells crawl. Am. Sci. 78:408-423; 1990.
10. Birchmeier, C.; Gherardi, E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell. Biol. 8:404-410; 1998.
11. Furge, K. A.; Zhang, Y. W.; Vande Woude, G. F. Met receptor tyrosine kinase: Enhanced signaling through adapter proteins. Oncogene 19:5582-5589; 2000.
12. Beilmann, M.; Odenthal, M.; Jung, W.; Vande Woude, G. F.; Dienes, H. P.; Schirmacher, P. Neoexpression of the c-Met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 90:4450-4458; 1997.
13. Beilmann, M.; Vande Woude, G. F.; Dienes, H. P.; Schirmacher, P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95:3964-3969; 2000.
14. Galimi, F.; Cottone, E.; Vigna, E.; Arena, N.; Boccaccio, C.; Giordano, S.; Naldini, L.; Comoglio, P. M. Hepatocyte growth factor is a regulator of monocyte-macrophage function. J. Immunol. 166:1241-1247; 2001.
15. Jeffers, M.; Rong, S.; Vande Woude, G. F. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J. Mol. Med. 74:505-505; 1996.
16. Jeffers, M.; Rong, S.; Vande Woude, G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16:1115-1125; 1996.
17. Jeffers, M.; Fiscella, M.; Webb, C. P.; Anver, M.; Koochekpour, S.; Vande Woude, G. F. The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA 95:14417-14422; 1998.
18. Jeffers, M.; Rong, S.; Anver, M.; Vande Woude, G. F. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 13:853-856; 1996.
19. Comoglio, P. M.; Boccaccio, C. Scatter factors and invasive growth. Semin. Cancer Biol. 11:153-165; 2001.
20. Rosen, E. M.; Joseph, A.; Jin, L.; Yao, Y.; Chau, M. H. T.; Fuchs, A.; Gomella, L.; Hastings, H.; Goldberg, I. D.; Weiss, G. H. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. J. Urol. 157:72-78; 1997.
21. Watanabe, M.; Fukutome, K.; Kato, H.; Murata, M.; Kawamura, J.; Shiraishi, T.; Yatani, R. Progression-linked over-expression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers. Cancer Lett. 141:173-178; 1999.
22. Imai, J.; Watanabe, M.; Sasaki, M.; Yamaguchi, R.; Tateyama, S.; Sugano, S. Induction of c-Met protooncogene expression at the metastatic site. Clin. Exp. Metastasis 17:457-462; 1999.
23. Rusciano, D.; Lin, S.; Lorenzoni, P.; Casella, N.; Burger, M. M. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells. Tumor Biol. 19:335-345; 1998.
24. Elia, G.; Ren, Y.; Lorenzoni, P.; Zarnegar, R.; Burger, M. M.; Rusciano, D. Mechanisms regulating c-Met overexpression in liver-metastatic B16-LS9 melanoma cells. J. Cell Biochem. 81:477-487; 2001.
25. Rusciano, D.; Lorenzoni, P.; Burger, M. M. Regulation of c-Met expression in B16 murine melanoma cells by melanocyte stimulating hormone. J. Cell Sci. 112:623-630; 1999.
26. Siegrist, W.; Drozdz, R.; Cotti, R.; Willard, D. H.; Wilkinson, W. O.; Eberle, A. N. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: Evidence for inverse agonism of agouti. J. Recept. Signal Transduct. Res. 17:75-98; 1997.
27. Ollmann, M. M.; Lamoreux, M. L.; Wilson, B. D.; Barsh, G. S. Interaction of agouti protein with the melanocortin I receptor in vitro and in vivo. Genes Dev. 12:316-330; 1998.
28. Anderson, M. K.; Hernandez-Hoyos, G.; Diamond, R. A.; Rothenberg, E. V. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126:3131-3148; 1999
29. Kosano, H.; Setogawa, T.; Kobayashi, K.; Nishigori, H. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by α-melanocyte stimulating hormone in murine B16 melanoma cells. Life Sci. 56:1707-1713; 1995.
30. Church, G. M.; Gilbert, W. Genome sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995; 1984.
31. Cao, B.; Su, Y. M.; Oskarsson, M.; Zhao, P.; Kort, E. J.; Fisher, R. J.; Wang, L-M.; Vande Woude, G. F. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA 98:7443-7448; 2001.
32. Kolatsi-Joannou, M.; Woolf, A. S.; Hardman, P.; White, S. J.; Gordge, M. ; Henderson, R. M. The hepatocyte growth factor/scatrter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells. J. Cell Sci. 108:3703-3714; 1995.
33. Yamamoto, Y.; Livet, J.; Pollock, R. A.; Garces, A.; Arce, V.; DeLapeyricre, O.; Henderson. C. E. Hepatocyte growth factor (HGF/SF) is a musclc-derived survival factor for a subpopulation of embryonic motoneurons. Development 124:2903-2913; 1997.
34. Zhang, X.; Liu, Y. Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. Am. J. Physiol. Renal Physiol. 284:-F1216-1225; 2003.
35. Bottaro, D. P.; Rubin, J. S.; Faletto, D. L.; Chan, A. M.; Kmiecik, T. E.; Vande Woude, G. F.; Aaronson, S. A. Identification of the hepatocyte growth factor receptor as the c-Met proto-oncogene product. Science 251:802-804; 1991.
36. Nguyen, L.; Holgado-Madruga, M.; Maroun, C.; Fixman, E. D.; Kamikura, D. ; Fournier, T.; Charest, A.; Tremblay, M. L.; Wong, A. J.; Park, M. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a function Grb2 binding site involving tyrosine 1356. J. Biol. Chem. 272:20811-20819;1997.
37. Sonnenberg, E.; Meyer, D.; Weidner, K. M.; Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-Met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223-235; 1993.
38. Matsumoto, K.; Nakamura, T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 119:591-600; 1996.
39. Zhang, L.; Himi, T.; Morita, I.; Murota, S. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J. Neurosci. Res. 59:489-496; 2000.
40. Bussolino, F.; Di Renzo, M. F.; Ziche, M.; Bocchietto, E.; Olivero, M.; Naldini, L.; Gaudino, G.; Tamagnone, L.; Coffer, A.; Comoglio, P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:629-641; 1992.
41. Grant, D. S.; Kleinman, H. K.; Goldberg, I. D.; Bhargava, M. M.; Nickoloff, B. J.; Kinsella, J. L.; Polverini, P.; Rosen, E. M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90: 1937-1941; 1993.
42. Bardelli, A.; Longati, P.; Gramaglia, D.; Basilico, C.; Tamagnone, L.; Giordano, S.; Ballinari, D.; Michieli, P.; Comoglio, P. M. Uncoupling signal transducers from oncogenic Met mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl. Acad. Sci. USA 95: 14379-14383; 1998.
43. Rong, S.; Segal, S.; Anver, M.; Resau, J. H.; Vande Woude, G. F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91: 4731-4735; 1994.
44. Stoker, M.; Gherardi, E.; Perryman, M.; Gray, J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:239-242; 1987.
45. Di Renzo, M. F.; Olivero, M.; Ferro, S.; Prat, M.; Bongarzone, I.; Pilotti, S.; Belfiore, A.; Costantino, A.; Vigneri R.; Pierotti, M. A.; Comoglio, P. M. Overexpression of the c-Met/HGF receptor gene in human thyroid carcinomas. Oncogene 7:2549-2553; 1992.
46. Ferracini, R.; Longati, P.; Naldini, L.; Vigna, E.; Comogsite of the Met/hepatocyte growth factor receptor tyrosine kinase. J. Biol. Chem. 266:19558-19564; 1991.
47. Prat, M.; Narsimhan, R. P.; Crepaldi, T.; Nicotra, M. R.; Natali, P. G.; Comoglio, P. M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 49:323-328; 1991.
48. Rong, S.; Jeffers, M.; Resau, J. H.; Tsarfaty, I.; Oskarsson, M.; Vande Woude, G. F. Met expression and sarcoma tumorigenicity. Cancer Res. 53:5355-5360; 1993.
49. Nakamura, T.; Kanda, S.; Yamamoto, K.; Kohno, T.; Maeda, K.; Matsuyama, T.; Kanetake, H. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Oncogene 20:7610-7623; 2001.
50. Tuck, A. B.; Park, M.; Sterns, E. E.; Boag, A.; Elliott, B. E. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148: 225-232; 1996.
51. Natali, P. G.; Nicotra, M. R.; Di Renzo, M. R.; Prat, M.; Bigotti, A.; Cavaliere, R.; Comoglio, P. M. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: Demonstration of the relationship to malignant melanoma tumor progression. Br. J. Cancer 68:746-750; 1993.
52. Weidner, K. M.; Behrens, J.; Vandekerckhove, J.; Birchmeier, W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111:2097-2108; 1990.
53. Matsumoto, K.; Matsumoto, K.; Nakamura, T.; Kramer, R. H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269: 31807-31813; 1994.
54. Bellusci, S.; Moens, G.; Gaudino, G.; Comoglio, P. M.; Nakamura, T.; Thiery, J. P.; Jouanneau, J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091-1099; 1994.
55. Rosen, E. M.; Nigam, S. K.; Goldberg, I. D. Scatter factor and the c-Met receptor: A paradigm for mesenchymal/epithelial interaction. J. Cell Biol. 127:1783-1787; 1994.
56. Rosen, E. M.; Knesel, J.; Goldberg, I. D.; Jin, L.; Bhargava, M.; Joseph, A.; Zitnik, R.; Wines, J.; Kelley, M.; Rockwell, S. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer 57:706-714; 1994.
57. Shimao, Y.; Nabeshima, K.; Inoue, T.; Koono. M. Role of fibroblast is HGF/SF-induced cohort migration of human colorectal carcinoma cells: Fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-β1. Int. J. Cancer 82:449-458; 1999.
58. Mensing, H.; Pontz, B.; Muller, P. K.; Gauss-Muller, V. A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. Eur. J. Cell Biol. 29:268-273; 1983.
59. Weimar, I. S.; De Jong, D.; Muller, E. J.; Nakamura, T.; Van Gorp, J. M. ; De Gast, G. C.; Gerritsen, W. R. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via αβ1 and α5β1 integrins. Blood 89:990-1000; 1997.
60. Van der Voort, R.; Taher, T. E.; Keehnen, R. M.; Smit, L.; Groenink, M.; Pals, S. T. Paracrine regulation of germinal center B cell adhesion through the c-Met-hepatocyte growth factor/scatter factor pathway. J. Exp. Med. 185: 2121-2131; 1997.
61. Trusolino, L.; Serini, G.; Cecchini, G.; Besati, C.; Ambesi-Impiombato, F. S.; Marchisio, P. C.; de Filippi, R. Growth factor-dependent activation of αvβ3 integrin in normal epithelial cells: Implications for tumor invasion. J. Cell Biol. 142:1145-1156; 1998.
62. Gambarotta, G.; Boccaccio, C.; Giordano, S.; Ando, M.; Stella, M. C.; Comoglio, P. M. Ets up-regulates MET transcription. Oncogene 13:1911-1917; 1996.
63. Seol, D. W.; Zarnegar, R. Structural and functional characterization of the mouse c-Met proto-oncogene (hepatocyte growth factor receptor) promoter. Biochim. Biophys. Acta 1395:252-258; 1998.
64. Wernert, N.; Raes, M.-B.; Lassalle, P.; Dehouck, M.-P.; Gosselin, B.; Vandenbunder, B.; Stehelin, D. c-Ets1 protooncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140:119-127; 1992.
65. Wernert, N.; Gilles, F.; Fafeur, V.; Bouali, F.; Raes, M. B.; Pyke, C.; Dupressoir, T.; Seitz, G.; Vandenbunder, B.; Stehelin, D. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res. 54: 5683-5688; 1994.
66. Herynk, M. H.; Radinsky, R. The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis. In Vivo 14:587-596; 2000.
67. Stetler-Stevenson, W. G.; Aznavoorian, S.; Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:541-573; 1993.
68. Hanzawa, M.; Shindoh, M.; Higashino, F.; Yasuda, M.; Inoue, N.; Hida, K. ; Ono, M.; Kohgo, T.; Nakamura, M.; Notani, K.; Fukuda, H.; Totsuka, Y.; Yoshida K.; Fujinaga, K. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21:1079-1085; 2000.
69. Jiang, Y.; Xu, W.; Lu, J.; He, F.; Yang, X. Invasiveness of hepatocellular carcinoma cell lines: Contribution of hepatocyte growth factor, c-Met, and transcription factor Ets-1. Biochim. Biophys. Res. Commun. 286:1123-1130; 2001.
70. Chakraborty, A. K.; Slominski, A.; Pawelek, J. Ultraviolet and melanocyte-stimulating hormone (MSH) stimulate mRNA production for αMSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J. Invest. Dermatol. 105:655-659; 1995.
71. Chakraborty, A. K.; Funasaka, Y.; Slominski, A.; Ermak, G.; Hwang, J.; Pawelek, J.; Ichihashi, M. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: Regulation by UVB. Biochem. Biophys. Acta 1313:130-138; 1996.
72. Mine, S.; Tanaka, Y.; Suematu, M.; Aso, M.; Fujosaki, T.; Yamada, S.; Eto, S. Hepatocyte growth factor is a potent trigger of neutrophil adhesion through rapid activation of lymphocyte function-associated antigen-1. Lab. Invest. 78:1395-1404; 1998.